DOX: Future Share Repurchases And EPS Recovery Will Support Multiple Rerating

Analysts have trimmed their price target for Amdocs to about $81 from about $90, citing lower sector P/E multiples, even as projections for profit margin and discount rate assumptions have been adjusted.

Analyst Commentary

Bullish and bearish analysts are looking at the same set of inputs for Amdocs and reaching very different conclusions, which is why you see both Buy ratings and a Sell rating alongside lower price targets clustered in the low to high US$70s.

Bullish Takeaways

Bullish analysts keep Buy ratings even with trimmed targets, signaling they still see room for upside relative to current sector P/E levels.
They highlight what they describe as a "robust quarter" as support for the investment case, suggesting company execution is tracking with their expectations.
Lower price targets tied to peer multiple compression indicate the adjustment is more about sector valuation resets than a shift in their view of Amdocs' underlying business drivers.
Revised targets in the US$71 to US$78 range still reflect confidence that, if current trends hold, the stock could justify a valuation higher than where cautious analysts place it.

Bearish Takeaways

Bearish analysts have moved to a Sell rating, signaling concern that the stock price already reflects, or exceeds, what they see as fair value given sector P/E pressure.
The downgrade aligns with the broader cut in price targets across research, pointing to worries that sector-wide multiple compression could limit upside even if company execution is steady.
They appear cautious that recent valuation resets, from around US$88 to US$71 and from US$97 to US$78, may still not fully capture potential downside risk if sentiment toward the sector weakens further.
This camp is more focused on downside protection, viewing the balance between execution, growth expectations and current valuation as skewed toward risk rather than opportunity.

What's in the News

Amdocs reported Q1 2026 revenue of US$1.17b, a 3.9% year over year increase, with adjusted EPS of US$1.78 slightly ahead of analyst estimates. Source: recent earnings coverage.
Full year adjusted EPS guidance came in weaker than projections, reflecting softer adjusted operating income and profitability, partly linked to a one time US$100m expense that management does not expect to recur. Source: recent earnings coverage.
Management highlighted ongoing demand for telecom automation and modernization, pointing to new customer wins and early agreements for the agentic operating system aOS. Source: recent earnings coverage.
Amdocs updated guidance for fiscal 2026, now expecting revenue growth of 2.6% to 4.6% and constant currency revenue growth of 2.0% to 4.0%. Source: company guidance filing.
The company repurchased 1,877,457 shares for US$138m in Q1 2026, completing a total of 3,856,085 shares for US$297.6m under the buyback announced on May 8, 2025. Source: company buyback update.

Valuation Changes

Fair Value: Trimmed from $90.21 to $81.21, a reduction of about 10% in the modeled estimate.
Discount Rate: Adjusted slightly lower from 9.43% to 9.13%, reflecting a modest change in required return assumptions.
Revenue Growth: Tweaked from 4.04% to 3.99%, a very small shift in projected top line expansion.
Net Profit Margin: Lifted from 15.65% to 16.02%, indicating a slightly stronger profitability assumption in the model.
Future P/E: Reduced from 14.21x to 12.04x, a meaningful move that points to a lower valuation multiple being applied to future earnings.

15 views

Key Takeaways

Strong adoption of cloud, AI, and next-generation telecom solutions is expanding Amdocs' growth opportunities and strengthening revenue stability through recurring high-visibility contracts.
Amdocs' leadership in SaaS, automation, and integrated BSS/OSS offerings is driving margin improvement and a robust pipeline for future growth.
Heavy dependence on a few key telecom clients and slow growth in cloud, SaaS, and GenAI services could restrain revenue stability and future earnings.

Catalysts

About Amdocs

Through its subsidiaries, provides software and services to communications, entertainment, and media service providers worldwide.What are the underlying business or industry changes driving this perspective?

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization, with Amdocs winning new large-scale modernization and migration deals in cloud, generative AI, and data services-this is expanding its total addressable market and supporting sustained topline revenue growth.
The rapid shift to 5G and next-generation wireless is prompting significant investment from telecom providers in digital transformation and core systems upgrades, which Amdocs is capturing through high-visibility managed service contracts (with notable wins and extensions in Europe, North America, and Asia), thereby boosting recurring revenue and earnings stability.
Customer conversions from generative AI proof-of-concepts (POCs) to production rollouts are increasing, creating a growing pipeline of incremental revenue and potential for future net margin expansion as Amdocs leads in deploying AI-powered platforms for automation and customer experience.
Expansion of SaaS-based and cloud-native product lines, including ConnectX and eSIM platforms, is delivering double-digit growth and higher gross margins, improving both earnings visibility and operating margins as recurring revenue scales.
Increased demand for complex BSS/OSS solutions due to convergence of mobile, broadband, fiber and new digital brands is emerging as telcos seek to streamline operations and support new business models, favoring Amdocs' integrated offerings and driving backlog and forward-looking revenue higher.

Amdocs Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Amdocs's revenue will grow by 4.0% annually over the next 3 years.
Analysts assume that profit margins will increase from 11.8% today to 16.0% in 3 years time.
Analysts expect earnings to reach $832.7 million (and earnings per share of $7.66) by about June 2029, up from $545.8 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 12.1x on those 2029 earnings, up from 11.8x today. This future PE is lower than the current PE for the US IT industry at 19.6x.
Analysts expect the number of shares outstanding to decline by 3.48% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 9.13%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Persistent macroeconomic and geopolitical uncertainty is impacting customer spending behavior, with no signs of improvement in telco and media capital expenditures; this could constrain Amdocs' forward revenue growth and create earnings pressure if clients delay or reduce digital transformation budgets.
Client concentration risk remains elevated, as major wins and growth opportunities are tied to a handful of large telecom operators; customer attrition, contract renegotiations, or consolidation among these key clients could destabilize long-term revenue and diminish backlog visibility.
The shift to SaaS and cloud-native offerings, while showing traction, is not yet generating "hundreds of millions" in annual revenue and remains a relatively small portion of overall sales; slower than expected scaling of cloud revenues or failure to keep pace with nimbler, cloud-first competitors could compress both revenue and net margins.
Ongoing reliance on large, complex, multi-year transformation projects creates cyclical volatility and earnings risk-delays, project overruns, or customer-side migration challenges (as evidenced by long cloud migration timelines) could negatively impact revenue recognition and margin stability.
Expansion into GenAI and data services is in the early stages, with current contributions only "small increments" and customers still in exploratory phases; if GenAI deployment cycles remain protracted or prove less disruptive than expected, Amdocs may face slower growth in new business lines, limiting future revenue acceleration and hampering earnings expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $81.21 for Amdocs based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $105.0, and the most bearish reporting a price target of just $70.84.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $5.2 billion, earnings will come to $832.7 million, and it would be trading on a PE ratio of 12.1x, assuming you use a discount rate of 9.1%.
Given the current share price of $60.84, the analyst price target of $81.21 is 25.1% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Amdocs?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Cloud, AI And 5G Adoption Will Modernize Telecom And Media